155 related articles for article (PubMed ID: 25794069)
1. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
Doshi AM; Huang WC; Donin NM; Chandarana H
AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
3. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
5. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
[TBL] [Abstract][Full Text] [Related]
6. Visual Assessment of the Intensity and Pattern of T1 Hyperintensity on MRI to Differentiate Hemorrhagic Renal Cysts From Renal Cell Carcinoma.
Kim CW; Shanbhogue KP; Schreiber-Zinaman J; Deng FM; Rosenkrantz AB
AJR Am J Roentgenol; 2017 Feb; 208(2):337-342. PubMed ID: 27845847
[TBL] [Abstract][Full Text] [Related]
7. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
8. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma.
Kierans AS; Rusinek H; Lee A; Shaikh MB; Triolo M; Huang WC; Chandarana H
AJR Am J Roentgenol; 2014 Dec; 203(6):W637-44. PubMed ID: 25415729
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic outcomes of cystic renal cell carcinoma.
Donin NM; Mohan S; Pham H; Chandarana H; Doshi A; Deng FM; Stifelman MD; Taneja SS; Huang WC
Clin Genitourin Cancer; 2015 Feb; 13(1):67-70. PubMed ID: 25088469
[TBL] [Abstract][Full Text] [Related]
10. Cystic renal cell carcinomas: do they grow, metastasize, or recur?
Jhaveri K; Gupta P; Elmi A; Flor L; Moshonov H; Evans A; Jewett M
AJR Am J Roentgenol; 2013 Aug; 201(2):W292-6. PubMed ID: 23883243
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
12. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
13. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
[TBL] [Abstract][Full Text] [Related]
14. Preoperative decision making for renal cell carcinoma: cystic morphology in cross-sectional imaging might predict lower malignant potential.
Huber J; Winkler A; Jakobi H; Bruckner T; Roth W; Hallscheidt P; Daneshvar K; Hohenfellner M; Pahernik S
Urol Oncol; 2014 Jan; 32(1):37.e1-6. PubMed ID: 23587431
[TBL] [Abstract][Full Text] [Related]
15. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.
Childs DD; Clingan MJ; Zagoria RJ; Sirintrapun J; Tangtiang K; Anderson A; Leyendecker JR
AJR Am J Roentgenol; 2014 Oct; 203(4):W421-8. PubMed ID: 25247971
[TBL] [Abstract][Full Text] [Related]
16. Prediction of nuclear grade of clear cell renal cell carcinoma with MRI: intratumoral susceptibility signal intensity versus necrosis.
Chen J; Sun J; Xing W; Ding J; Chen T; Dai Y; Sun J; Hu J
Acta Radiol; 2014 Apr; 55(3):378-84. PubMed ID: 23946232
[TBL] [Abstract][Full Text] [Related]
17. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
18. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
